Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
That’s news to me. I think we would have seen a bit more action on the US market this evening if that was the case though. The price was flat when they joined just after lunch too. Although I don’t think FDA approval will take long. Once P3 starts I suspect things will start getting interesting with interim results.
@mrnation There have been a few posts over the last two weeks by someone suggesting Indian businesses men were loading up here . They were investing based on news from Sun Pharmaceuticals. The user was pmarrin I think. Could be absolutely boll0x though. I guess we will find out tomorrow.
Evening all,
It’s about time we had some good news here. I’ve not been as smart as many and have held firm since manic Monday, topping up along the way. I agree with others this feels very similar to the lead up to that magic day. We’ve just had the calm before the storm with low volumes and a slow fluctuating SP. And now the big spike in volume at the end of the day. Don’t worry about the missing buys they will appear tomorrow as late trades.
So on to my prediction, I think we will get a P3 - first patient dosed along with a large pre order or a licensing deal from Sun Pharma. We all know Synairgen like to do bumper RNSs so it’s unlikely to be just P3.
To back this up there has been some interesting changes on Google trends over the past week.
Sun Pharma now comes up as a related topic when searching for synairgen. It’s highly unlikely that’s just due to the rumour from these boards.
https://trends.google.com/trends/explore?date=now%207-d&q=Synairgen
Anyway we will find out for certain at 7am tomorrow. :)
Looks to be injected interferon given in early stages. The trial is just about to start in Chile.
https://www.uc.cl/en/news/concord-19-the-first-worldwide-clinical-study-starts-in-chile-to-stop-outbreaks-of-covid-19/
Links through to here:
http://www.isrctn.com/ISRCTN14241621
Don’t think I’ve seen this before, are we finally getting a bit of support to fill the hone trial:
https://bepartofresearch.nihr.ac.uk/results/search-results?query=*&location=&search=%257B%2522query%2522%253A%2522*%2522%252C%2522facetDef%2522%253A%257B%2522Health%2520Tag%2522%253A%255B%2522*All%2520COVID-19%2522%255D%252C%2522Study%2520Status%2522%253A%255B%2522Recruiting%2522%255D%252C%2522Gender%2522%253A%255B%255D%252C%2522Updated%2520Within%2522%253A%255B%255D%252C%2522Age%2520Range%2522%253A%255B%255D%257D%252C%2522rows%2522%253A%252210%2522%252C%2522offset%2522%253A%25220%2522%252C%2522openurl%2522%253A%2522yes%2522%252C%2522dist%2522%253A0%252C%2522sortBy%2522%253Anull%252C%2522sortOrder%2522%253Anull%257D
Not one to usually join in on an un-evidenced ramp or disprove of mr Bigs friends, sisters dogs choice in men but I thought this was interesting. https://trends.google.com/trends/explore?date=today%203-m&geo=IN&q=Synairgen
The only people searching Synairgen in India in the last 30 days were located in West Bengal were Sun Pharma have an office. Of course they have offices across most of the world so this could be absolute ****** and me unintentionally ramping someone else’s ramping ******! It’s been a long day so I’m going to bed before I get flamed :-)
Sorry couldn’t resist. I expect a bit of a rally in the next hour as people clock in for possible p3 start RNS and for the yanks loading up after a few days break come Monday morning.
I think people are getting a bit to hung up on the 30. He says we currently have 30 enrolled on the home trial. To me this suggests patients which are being monitored and not those that have completed the trial. We also don’t know the date of the interview, he does say a few things which make me think this interview was taken several weeks ago. Some very big positives here, just wish it was advertised and shared more widely.
Haha not a chance Pete. I’be been here since May and will be seeing it though to the end. I’ve researched this until the cows come home and I’ve only invested what I can afford. If my research is wrong and I loose my investment then I can only blame myself. In my eyes the science outweighs the risk here but only in the long term.